» Articles » PMID: 26860319

LowMACA: Exploiting Protein Family Analysis for the Identification of Rare Driver Mutations in Cancer

Overview
Publisher Biomed Central
Specialty Biology
Date 2016 Feb 11
PMID 26860319
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The increasing availability of resequencing data has led to a better understanding of the most important genes in cancer development. Nevertheless, the mutational landscape of many tumor types is heterogeneous and encompasses a long tail of potential driver genes that are systematically excluded by currently available methods due to the low frequency of their mutations. We developed LowMACA (Low frequency Mutations Analysis via Consensus Alignment), a method that combines the mutations of various proteins sharing the same functional domains to identify conserved residues that harbor clustered mutations in multiple sequence alignments. LowMACA is designed to visualize and statistically assess potential driver genes through the identification of their mutational hotspots.

Results: We analyzed the Ras superfamily exploiting the known driver mutations of the trio K-N-HRAS, identifying new putative driver mutations and genes belonging to less known members of the Rho, Rab and Rheb subfamilies. Furthermore, we applied the same concept to a list of known and candidate driver genes, and observed that low confidence genes show similar patterns of mutation compared to high confidence genes of the same protein family.

Conclusions: LowMACA is a software for the identification of gain-of-function mutations in putative oncogenic families, increasing the amount of information on functional domains and their possible role in cancer. In this context LowMACA emphasizes the role of genes mutated at low frequency otherwise undetectable by classical single gene analysis. LowMACA is an R package available at http://www.bioconductor.org/packages/release/bioc/html/LowMACA.html. It is also available as a GUI standalone downloadable at: https://cgsb.genomics.iit.it/wiki/projects/LowMACA.

Citing Articles

A unified analysis of evolutionary and population constraint in protein domains highlights structural features and pathogenic sites.

MacGowan S, Madeira F, Britto-Borges T, Barton G Commun Biol. 2024; 7(1):447.

PMID: 38605212 PMC: 11009406. DOI: 10.1038/s42003-024-06117-5.


DeepAlloDriver: a deep learning-based strategy to predict cancer driver mutations.

Song Q, Li M, Li Q, Lu X, Song K, Zhang Z Nucleic Acids Res. 2023; 51(W1):W129-W133.

PMID: 37078611 PMC: 10320081. DOI: 10.1093/nar/gkad295.


A New View of Activating Mutations in Cancer.

Nussinov R, Tsai C, Jang H Cancer Res. 2022; 82(22):4114-4123.

PMID: 36069825 PMC: 9664134. DOI: 10.1158/0008-5472.CAN-22-2125.


PertInInt: An Integrative, Analytical Approach to Rapidly Uncover Cancer Driver Genes with Perturbed Interactions and Functionalities.

Kobren S, Chazelle B, Singh M Cell Syst. 2020; 11(1):63-74.e7.

PMID: 32711844 PMC: 7493809. DOI: 10.1016/j.cels.2020.06.005.


Identification of pathogenic variant enriched regions across genes and gene families.

Perez-Palma E, May P, Iqbal S, Niestroj L, Du J, Heyne H Genome Res. 2019; 30(1):62-71.

PMID: 31871067 PMC: 6961572. DOI: 10.1101/gr.252601.119.


References
1.
Valdar W . Scoring residue conservation. Proteins. 2002; 48(2):227-41. DOI: 10.1002/prot.10146. View

2.
Futreal P, Coin L, Marshall M, Down T, Hubbard T, Wooster R . A census of human cancer genes. Nat Rev Cancer. 2004; 4(3):177-83. PMC: 2665285. DOI: 10.1038/nrc1299. View

3.
Maglott D, Ostell J, Pruitt K, Tatusova T . Entrez Gene: gene-centered information at NCBI. Nucleic Acids Res. 2004; 33(Database issue):D54-8. PMC: 539985. DOI: 10.1093/nar/gki031. View

4.
Wennerberg K, Rossman K, Der C . The Ras superfamily at a glance. J Cell Sci. 2005; 118(Pt 5):843-6. DOI: 10.1242/jcs.01660. View

5.
Gouw L, Reading N, Jenson S, Lim M, Elenitoba-Johnson K . Expression of the Rho-family GTPase gene RHOF in lymphocyte subsets and malignant lymphomas. Br J Haematol. 2005; 129(4):531-3. DOI: 10.1111/j.1365-2141.2005.05481.x. View